Keywords: first, phase, iii, data, roche/trimeris, hiv, drug

First Phase III data for Roche/Trimeris HIV drug bodes well for approval in 2003

Article | 22 April 2002

• Print This

T-20, the HIV fusion inhibitor in development at Roche and Trimeris, hasbeen shown in a Phase III study to offer ...

Enjoying this article? To continue reading you need to login or subscribe.